SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-15-039839
Filing Date
2015-11-05
Accepted
2015-11-05 17:25:33
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP. 10-Q 9-30-2015 form10q.htm 10-Q 1054553
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 70339
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 11300
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 11145
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 11839
  Complete submission text file 0001140361-15-039839.txt   4953061

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rptp-20150930.xml EX-101.INS 793586
7 XBRL TAXONOMY EXTENSION SCHEMA rptp-20150930.xsd EX-101.SCH 38879
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20150930_cal.xml EX-101.CAL 60100
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20150930_def.xml EX-101.DEF 168347
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20150930_lab.xml EX-101.LAB 581125
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20150930_pre.xml EX-101.PRE 319497
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 151201772
SIC: 2834 Pharmaceutical Preparations